{"id":"W4386905499","doi":"10.14740/wjon1604","title":"Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Internal medicine; Confidence interval; Hazard ratio; Retrospective cohort study; Neutropenia; Pancreatic cancer; Odds ratio; Anemia; Diarrhea; Oncology; Gastroenterology; Surgery; Chemotherapy; Cancer; Irinotecan","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004275362,0.0007325037,0.02646292,0.001189534,0.0002352375,0.00003353914,0.000498609,0.00032989,0.0006634628],"category_scores_gemma":[0.001744034,0.0003261472,0.005825257,0.001832674,0.0002858074,0.00005291338,0.0001179194,0.0007589482,0.00006069125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00144518,"about_ca_system_score_gemma":0.002357802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001758598,"about_ca_topic_score_gemma":0.001443008,"domain_scores_codex":[0.9937019,0.001135537,0.003470899,0.0004862476,0.0005754009,0.000629977],"domain_scores_gemma":[0.9882639,0.006504973,0.003355797,0.0008475676,0.0006753365,0.0003524418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001337522,0.0002776448,0.00003413317,0.5454303,0.4382557,0.0003819827,0.00008196357,8.776511e-7,1.340943e-8,0.0001174975,0.004267467,0.01101864],"study_design_scores_gemma":[0.0009320042,0.002468031,0.00000659837,0.02505103,0.5746847,0.00106501,0.00001701095,0.0000100743,2.104828e-8,0.00008274781,0.395548,0.0001347575],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005753632,0.9713805,0.00004445455,0.0198158,0.0001244571,0.008076158,0.0001226275,0.00001919157,0.0004109976],"genre_scores_gemma":[0.000009721116,0.9653312,0.0004300322,0.002142767,0.0003232254,0.004439952,0.00003577012,0.00008176878,0.02720559],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5203793,"threshold_uncertainty_score":0.9999191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2444385207205781,"score_gpt":0.4941930577811587,"score_spread":0.2497545370605806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}